ADIL Adial Pharmaceuticals, Inc.

NASDAQ
$4.86

Adial Pharmaceuticals, Inc. (ADIL) SEC Filings

Everything ADIL has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

16 filings
Date Form Filing
8-K Executive Change · Material Agreement · Other
8-K Material Agreement · Other · Other Event
8-K Capital Raise · Dilution
8-K Delisting
8-K Acquisition Disposition · Capital Raise · Earnings Release · Executive Change
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.